Table 2. Outcome stratified by clinical stage.

		Cystectomy procedure
		Open	Robotic	P
	≤cT1	25 (27.5)	37 (30.8)
Clinical bladder cancer stage (n; %)	cT2	45 (49.5)	65 (54.2)	0.437
	cT3	15(16.5)	11 (9.2)
	cT4/node positive (N1/N2)	6 (6.6)	7 (5.8)
Patients with muscle-invasive tumors (n: %)		66 (72.5)	83 (69.2)	0.649
	All stages	12.6(9.3-15.9)	11.8(7.7-15.9)	0.949
	≤cT1	17.3(9.6-25.1)	13.2(4.5-21.8)	0.858
Time to recurrence (mean; 95% CI) (months)	cT2	15.9(10.8-20.9)	12.8(7.8-17.8)	0.318
	cT3	5.8 (2.8-8.7)	16.0(0.0-39.6)	0.410
	cT4/node positive (N1/N2)	5.0 (2.7-7.3)	3.3(0.01-6.5)	0.841
	All stages	66.9 (55.3-78.6)	68.8 (59.6-77.9)	0.301
	≤cT1	74.3 (54.7-93.9)	67.5(57.1-77.9)	0.531
Time to all-cause death (mean; 95% CI) (months)	cT2	74.4 (58.8-90.0)	72.4 (59.9-84.9)	0.416
	cT3	24.6(14.2-35.1)	26.6(18.5-34.8)	0.459
	cT4/node positive (N1/N2)	50.2(16.6-83.7)	30.3(14.4-46.2)	0.864